Posts tagged “UNC-CH”
GlaxoSmithKline is boosting its own efforts to fight AIDS by agreeing to buy the HIV drug pipeline of Bristol-Myers Squibb in a deal valued at as much as $1.46 billion. In May, GSK said it would invest $20 million in a deal with UNC-Chapel Hill to develop an AIDS cure.
Global Entrepreneurship Week wound down this weekend. After 23 events, organizers and participants reflect on the experience. Some were so excited, they produced their own teaser music video.
Spellings to head UNC system, Biomedical scholars named, Charlotte, Raleigh 2,3 in Metro wage disparity
In today's Bulldog update of technology news: UNC names former Secretary of Education to head university system; UNC School of Medicine researcher get Biomedical Scholars Award; Raleigh wage inequality third in the nation. Charlotte landed at number 2. Atlanta is at Number 10.
The University of North Carolina at Chapel Hill is the top overall graduate school for business and management, according to Graduateprograms.com, which has released its fall 2015 rankings and UNC-CH was cited for three other programs. Duke University ranked first in three categories.
Just two blocks off the UNC-Chapel Hill campus, Launch Chapel Hill serves as the unofficial headquarters for startup activity in Chapel Hill and Orange County. Results since its January 2013 launch include" 49 startups, 94 jobs, and $3.7 million in funding. Out partner site Exit Event provides a closer look at the accelerator.
Canadian scientist Arthur B. McDonald, one of two scientists awarded the 2015 Nobel Prize for Physics, led a research project that included physicists at the University of North Carolina at Chapel Hill.
The University of North Carolina at Chapel Hill has invited entrepreneurs, venture capitalists and other thought leaders to help advance innovative solutions to local and global challenges at "Outside In: 2015 Chancellor's Innovation Summit" on Friday, Oct. 9.
A UNC Lineberger Comprehensive Cancer Center researcher is working to fight a growing type of head and neck cancer by partnering with a California company to develop a rapid oral test for HPV, a virus linked to cancer.
Joseph M. DeSimone, chancellor's eminent professor of Chemistry at the University of North Carolina at Chapel Hill, has been named the recipient of the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine. He won for his invention and use of PRINT, a breakthrough technology that has been used to make advances toward the development of new cancer treatments, inhalable therapeutics and next generation vaccines for malaria, pneumonia and dengue.
Online business education and career guide Top Management Degrees has published a meta-ranking of the 50 best online MBA programs (hThe University of North Carolina at Chael Hill Kenan-Flagler Business School was the highest ranked NC school, coming in at number 11. Online Schools Center offers a separate listing of best online MBA programs.
University of North Carolina at Chapel Hill researchers received an $11.3 million, five-year grant to conduct multiple studies exploring the use of tiny nanoparticles to create cancer vaccines and improve cancer drug delivery and responses.
UNC wants NSF 'Big Data Hub;' virtual reality device is $15K; Yahoo's $23B snag; Mylan's $27B offer for Perrigo; Netflix expanding
In today's Bulldog wrapup of technology and life science news: UNC's RENCI computing and data center wants a NSF "Big Data Hub;" virtual reality filming device to sell for $15,000; Yahoo's $23 billion Alibaba deal faces big tax hurdle; Mylan bids for Perrigo; and Netflix plans Asia expansion.
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have for the first time created and used a nanoscale vehicle made of DNA to deliver a gene-editing tool into cells in both cell culture and an animal model.
What do Mark Zukcerberg, Sergey Brin, Larry Page and Zhen Gu have in common? Zhen Gu, a researcher at N.C. State and UNC-Chapel Hill sine 2012, is one of the select few named to the prestigious MIT Tech Review's "35 Innovators Under 35" list.
G1 Therapeutics, a Research Triangle Park clinical-stage oncology company backed by Fred Eshelman, has begun two clinical trials of a new therapy aimed at protecting the bone marrow and immune systems of patients undergoing chemotherapy for small-cell lung cancer.
Inventors, innovators, entrepreneurs and startups have a new resource from which to draw a variety of support, including funding. It's the Technology Commercialization Center at UNC, launching with $2.2 million in funding.
- No-tipping trend now at more restaurants, with mixed results
- iRobot CEO says vacuum cleaners clear path to robot future
- Samsung updates smartwatch, Lenovo ditches laptop keyboard
- Survey: US companies add a solid 177,000 jobs in August
- Ex-NCSU football players seeking $200,000 for startup Gryppers (+ video)